We are rapidly transitioning into an era where software platforms will be treating millions of patients, - thanks to the huge advancements in digital health innovation
The three-day initial public offering (IPO) will be offered for subscription on April 25-27, with bidding for anchor investors beginning on April 24. Mankind Pharma's initial public offering is scheduled to begin trading next week, with a price...
Artificial Intelligence (AI) is transforming the healthcare industry in many ways, and drug discovery is no exception. AI has the potential to revolutionize drug discovery by increasing the efficiency and accuracy of the process.
China's pharmaceutical firm Hasten Biopharmaceutic has raised $315 million in a fundraising round co-led by Asia's largest healthcare investment firm CBC Group and Abu Dhabi sovereign wealth fund Mubadala Investment Company....
Moderna, Inc., a biotechnology company that pioneered messenger RNA (mRNA) therapeutics and vaccines, and IBM announced a collaboration in which Moderna will investigate next-generation technologies such as quantum computing and artificial....
The World Health Organisation (WHO) has released three online resources to help countries improve the execution of NTD programmes: an interactive dashboard, an online training course, and a mobile application. The World Health Organisation (WHO)...
US CDC Approves Second Omicron-Updated COVID Booster For Adults. The agency's decision follows the FDA's approval on Tuesday of a second dose of Omicron-updated booster for the specified high-risk population.
Marksans Pharma Limited, an Indian pharmaceutical business, has completed the acquisition of a production facility from Tevapharm India, according to an exchange filing. The deal was first announced in October 2022...
Motherhood Hospitals, which operates 21 hospitals in ten cities, has implemented a novel remote patient monitoring technology and system to provide virtual life-saving neonatal care to newborns admitted to nursing homes and hospitals in semi-urban...
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company addressing serious diseases with significant unmet need, has signed a manufacturing collaboration agreement with Cook MyoSite, Inc. (Cook MyoSite) to facilitate Chemistry,...
, CDSCO.jpg)
